Alison M Michie

15PUBLICATIONS
61CO-AUTHORS
Molecular targetsHaematologyInnate immunityHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Apr 25, 2025
The chemical chaperone 4-phenylbutyric acid rescues molecular cell defects of COL3A1 mutations that cause vascular Ehlers Danlos Syndrome.

Ramla Omar, Michelle Aw Lee, Laura Gonzalez-Trueba

|Jul 10, 2024
Bioengineered niches that recreate physiological extracellular matrix organisation to support long-term haematopoietic stem cells.

Hannah Donnelly, Ewan Ross, Yinbo Xiao

|May 30, 2024
IL-27 maintains cytotoxic Ly6C<sup>+</sup> γδ T cells that arise from immature precursors.

Robert Wiesheu, Sarah C Edwards, Ann Hedley

|Mar 08, 2024
The MYC-NFATC2 axis maintains the cell cycle and mitochondrial function in acute myeloid leukaemia cells.

Shaun D Patterson, Matthew E Massett, Xu Huang

|Jan 21, 2024
Activating p53 abolishes self-renewal of quiescent leukaemic stem cells in residual CML disease.

Mary T Scott, Wei Liu, Rebecca Mitchell

|Sep 29, 2023
mTORC1-selective activation of translation elongation promotes disease progression in chronic lymphocytic leukemia.

Natasha Malik, Jodie Hay, Hassan N B Almuhanna

Pageof 3

Frequent Collaborators

7 joint publications

Karen M Dunn

3 joint publications

Jodie Hay

3 joint publications

Mhairi Copland

3 joint publications

Mary T Scott